Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: J Cell Mol Med. 2010 Apr 19;15(5):1087–1095. doi: 10.1111/j.1582-4934.2010.01072.x

Fig. 5.

Fig. 5

CCN2 siRNA-mediated down regulation of integrin expression. mHSC on (A) Day 3 or (B) Day 7 were treated for 48 hr with siCCN2 (50 nM) prior to analysis of mRNA expression of the integrin α5, αv, β1 or β3 subunits by quantitative real-time PCR. Data are the means ± SD of triplicate determinations and are representative of three independent experiments. *p<0.05 vs Ctrl. (C) Immunofluorescent detection of CCN2 in Day 1 (without siCCN2 treatment), Day 3 or Day 7 mHSC treated with or without siCCN2 (magnification X100). NC, negative control.